Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
This facility marks a significant milestone in transforming the global food industr
Harnessing advanced data analysis for early detection, prevention and better outcomes
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The agreement sets terms under which POC will manufacture the product or receive royalties
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Subscribe To Our Newsletter & Stay Updated
